JCIA
NRIX icon

Jackson Creek Investment Advisors’s Nurix Therapeutics NRIX Stock Holding History

Jackson Creek Investment Advisors’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-49,662
Closed -$545K – 350
2022
Q4 		$545K Sell
49,662
-5,313
-10% -$64.1K 0.24% 220
2022
Q3 		$716K Sell
54,975
-82
-0.1% -$1.3K 0.34% 168
2022
Q2 		$879K Buy
+55,057
New +$624K 0.36% 163

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jackson Creek Investment Advisors's NRIX Position: Q1 2023 in Review

Jackson Creek Investment Advisors sold out of Nurix Therapeutics (NRIX) in Q1 2023, closing a stake of 49,662 shares — an estimated $545K sold.

Jackson Creek Investment Advisors first reported a position in NRIX in Q2 2022 and held it in 3 quarters. The position peaked at $879K in Q2 2022. 123 funds tracked by Wall St. Rank hold NRIX as of Q1 2023.

  • Jackson Creek Investment Advisors reported no remaining Nurix Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 49,662 Nurix Therapeutics shares in Q1 2023, an estimated $545K.
  • Jackson Creek Investment Advisors first reported a position in Nurix Therapeutics in Q2 2022 and held it in 3 quarters.
  • Jackson Creek Investment Advisors's Nurix Therapeutics position peaked at $879K in Q2 2022.
  • 123 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2023.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2023, filed 2 May 2023.